Literature DB >> 24145327

Transplantation: Autoantibodies-epiphenomena or biological clues.

Philip F Halloran1.   

Abstract

The potential roles for autoantibodies in renal transplantation are increasing, as illustrated by a recent report of polyreactive autoantibodies produced by B-cell clones from a kidney transplant recipient that can bind apoptotic cells and activate complement. Such autoantibodies have the potential to amplify microcirculation injury caused by alloantibody in antibody-mediated transplant rejection.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24145327     DOI： 10.1038/nrneph.2013.221

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

1.  Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures.

Authors:  Li Li; Persis Wadia; Rong Chen; Neeraja Kambham; Maarten Naesens; Tara K Sigdel; David B Miklos; Minnie M Sarwal; Atul J Butte
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-27       Impact factor: 11.205

Review 2.  Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies.

Authors:  Philip F Halloran; Jeff P Reeve; Andre B Pereira; Luis G Hidalgo; Konrad S Famulski
Journal:  Kidney Int       Date:  2013-08-21       Impact factor: 10.612

3.  Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.

Authors:  Duska Dragun; Dominik N Müller; Jan Hinrich Bräsen; Lutz Fritsche; Melina Nieminen-Kelhä; Ralf Dechend; Ulrich Kintscher; Birgit Rudolph; Johan Hoebeke; Diana Eckert; Istvan Mazak; Ralph Plehm; Constanze Schönemann; Thomas Unger; Klemens Budde; Hans-Hellmut Neumayer; Friedrich C Luft; Gerd Wallukat
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

4.  Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans.

Authors:  Huijuan Lv; Evis Havari; Sheena Pinto; Raju V S R K Gottumukkala; Lizbeth Cornivelli; Khadir Raddassi; Takashi Matsui; Anthony Rosenzweig; Roderick T Bronson; Ross Smith; Anne L Fletcher; Shannon J Turley; Kai Wucherpfennig; Bruno Kyewski; Myra A Lipes
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

5.  Report from a consensus conference on antibody-mediated rejection in heart transplantation.

Authors:  Jon Kobashigawa; Maria G Crespo-Leiro; Stephan M Ensminger; Hermann Reichenspurner; Annalisa Angelini; Gerald Berry; Margaret Burke; Lawrence Czer; Nicola Hiemann; Abdallah G Kfoury; Donna Mancini; Paul Mohacsi; Jignesh Patel; Naveen Pereira; Jeffrey L Platt; Elaine F Reed; Nancy Reinsmoen; E Rene Rodriguez; Marlene L Rose; Stuart D Russell; Randy Starling; Nicole Suciu-Foca; Jose Tallaj; David O Taylor; Adrian Van Bakel; Lori West; Adriana Zeevi; Andreas Zuckermann
Journal:  J Heart Lung Transplant       Date:  2011-03       Impact factor: 10.247

6.  Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients.

Authors:  Laurie D Snyder; Ziwei Wang; Dong-Feng Chen; Nancy L Reinsmoen; C Ashley Finlen-Copeland; W Austin Davis; David W Zaas; Scott M Palmer
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

7.  B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans.

Authors:  F Porcheray; W Wong; S L Saidman; J De Vito; T C Girouard; M Chittenden; J Shaffer; N Tolkoff-Rubin; B R Dey; T R Spitzer; R B Colvin; A B Cosimi; T Kawai; D H Sachs; M Sykes; E Zorn
Journal:  Am J Transplant       Date:  2009-07-16       Impact factor: 8.086

8.  Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement.

Authors:  F Porcheray; J W Fraser; B Gao; A McColl; J DeVito; I Dargon; Y Helou; W Wong; T C Girouard; S L Saidman; R B Colvin; A Palmisano; U Maggiore; A Vaglio; R N Smith; E Zorn
Journal:  Am J Transplant       Date:  2013-08-06       Impact factor: 8.086

9.  Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation.

Authors:  R R Hachem; V Tiriveedhi; G A Patterson; A Aloush; E P Trulock; T Mohanakumar
Journal:  Am J Transplant       Date:  2012-05-08       Impact factor: 8.086

10.  The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia.

Authors:  Roxanna A Irani; Yujin Zhang; Sean C Blackwell; Cissy Chenyi Zhou; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307
  10 in total
  4 in total

1.  Alloantibodies and Allograft Arteriosclerosis: Accelerated Adversity Ahead?

Authors:  Richard N Pierson; Jonathan S Bromberg
Journal:  Circ Res       Date:  2015-08-14       Impact factor: 17.367

Review 2.  Molecular assessment of disease states in kidney transplant biopsy samples.

Authors:  Philip F Halloran; Konrad S Famulski; Jeff Reeve
Journal:  Nat Rev Nephrol       Date:  2016-06-27       Impact factor: 28.314

Review 3.  Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms.

Authors:  Emilie Lebraud; Maëva Eloudzeri; Marion Rabant; Baptiste Lamarthée; Dany Anglicheau
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

4.  Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Authors:  Marianne Delville; Baptiste Lamarthée; Sylvain Pagie; Sarah B See; Marion Rabant; Carole Burger; Philippe Gatault; Magali Giral; Olivier Thaunat; Nadia Arzouk; Alexandre Hertig; Marc Hazzan; Marie Matignon; Christophe Mariat; Sophie Caillard; Nassim Kamar; Johnny Sayegh; Pierre-François Westeel; Cyril Garrouste; Marc Ladrière; Vincent Vuiblet; Joseph Rivalan; Pierre Merville; Dominique Bertrand; Alain Le Moine; Jean-Paul Duong Van Huyen; Anne Cesbron; Nicolas Cagnard; Olivier Alibeu; Simon C Satchell; Christophe Legendre; Emmanuel Zorn; Jean-Luc Taupin; Béatrice Charreau; Dany Anglicheau
Journal:  J Am Soc Nephrol       Date:  2019-03-08       Impact factor: 10.121
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.